z-logo
Premium
Protective effects of glucagon‐like peptide 2 on intestinal ischemia‐reperfusion rats
Author(s) -
Zhang Wei,
Zhu Weiming,
Zhang Jian,
Li Ning,
Li Jieshou
Publication year - 2008
Publication title -
microsurgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.031
H-Index - 63
eISSN - 1098-2752
pISSN - 0738-1085
DOI - 10.1002/micr.20491
Subject(s) - medicine , glucagon like peptide 2 , superior mesenteric artery , laparotomy , proinflammatory cytokine , ischemia , reperfusion injury , intestinal ischemia , mesenteric lymph nodes , intestinal mucosa , group a , gastroenterology , endocrinology , anesthesia , surgery , inflammation , peptide , spleen , biochemistry , chemistry
Our objective was to evaluate the protective effects of glucagon‐like peptide 2 (GLP‐2) on intestinal ischemia/reperfusion (I/R) rats. Thirty‐two rats were randomly assigned to four experimental groups, each of 8: Group A, sham rats underwent laparotomy only, without superior mesenteric artery (SMA) occlusion; Group B, I/R animals underwent laparotomy and occlusion of the SMA for 60 minutes followed by 120 minutes of reperfusion; Group C, I/R animals underwent intestinal I/R, and received pretreatment with GLP‐2 for 3 days preoperatively; and Group D, I/R animals underwent intestinal I/R, received pretreatment with GLP‐2 as above, and during the reperfusion phase were injected intravenously with GLP‐2. After the reperfusion of intestinal ischemia, samples of intestinal mucosa, mesenteric lymph nodes (MLN) and blood were prepared for determination. In the pretreatment rats with GLP‐2 (group C), Chiu's scores, bacterial colony counts, serum D ‐lactate, intestinal mucosal MDA and ET‐1, and serum endotoxin, TNF‐α and IL‐6 were significantly reduced compared with intestinal I/R rats (group B). Administration of GLP‐2 during the reperfusion phase following pretreatment (group D) showed further protective effects in comparison with the pretreatment rats (group C). We conclude that treatment with GLP‐2 attenuates intestinal I/R injury, reduces bacterial translocation, inhibits the release of oxygen free radicals and ET‐1, and may well inhibit the production of proinflammatory cytokines. © 2008 Wiley‐Liss, Inc. Microsurgery, 2008.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here